This session will delve into how preclinical human data, derived from innovative methodologies such as organ-on-a-chip technology, lab-grown tissues, and advanced imaging techniques, can provide invaluable insights into drug efficacy and safety prior to clinical trials. Session panelists will discuss their experiences in leveraging this data to inform decision-making, streamline development processes, and ultimately accelerate the path from discovery to market. Attendees will learn about real-world applications, including how integrating preclinical human data into research pipelines can lead to better-targeted therapies and reduced failure rates in later-stage development. With insights from leading researchers and industry veterans, this discussion will highlight best practices for harnessing preclinical human data to de-risk drug development, ensuring that participants leave equipped with actionable strategies to enhance their own drug discovery efforts. Don't miss this opportunity to engage with experts shaping the future of drug development through data-driven approaches.